Local Anaesthetic for Transvaginal Egg Collection in IVF
Primary Purpose
Infertility
Status
Completed
Phase
Not Applicable
Locations
New Zealand
Study Type
Interventional
Intervention
lignocaine
normal saline
Sponsored by
About this trial
This is an interventional supportive care trial for Infertility focused on measuring oocyte retrieval, pain relief, Local anaesthetic
Eligibility Criteria
Inclusion Criteria:
- About to undergo transvaginal oocyte retrieval
Exclusion Criteria:
- Already undergone oocyte retrieval and participated in study (i.e. 2nd or more oocyte collection procedure during study period)
- Allergy to lignocaine
- Oocytes only to be collected from one ovary
- Procedure expected to be exceptionally painful
Sites / Locations
- The Fertility Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
LA
P
Arm Description
Intravaginal and pre-peritoneal injection of 1% lignocaine into each side of the upper vagina under ultrasound guidance immediately prior to ultrasound guided transvaginal oocyte retrieval
Intravaginal saline placebo injection into each side of upper vagina under ultrasound guidance immediately prior to transvaginal oocyte retrieval
Outcomes
Primary Outcome Measures
Total dose of iv fentanyl used during oocyte collection
Secondary Outcome Measures
Pain score (cm on a Visual Analogue Scale) at 6 different points during oocyte collection
Length of oocyte collection procedure
Occurence of nausea or vomiting
Administration of atropine or anti -emetic
Time spent in recovery room
No of oocytes collected
Number of oocytes fertilised
Pregnancy outcome
Number of embryos frozen
Pulse rate at beginning and end of egg collection
Maximum pulse rate during oocyte collection
Full Information
NCT ID
NCT00554424
First Posted
November 3, 2007
Last Updated
November 5, 2007
Sponsor
The Fertility Centre, New Zealand
1. Study Identification
Unique Protocol Identification Number
NCT00554424
Brief Title
Local Anaesthetic for Transvaginal Egg Collection in IVF
Official Title
A Randomised Controlled Trial of Intravaginal Lignocaine Injection Versus Placebo for Analgesia During Oocyte Recovery in an IVF Cycle
Study Type
Interventional
2. Study Status
Record Verification Date
November 2007
Overall Recruitment Status
Completed
Study Start Date
March 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2002 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
The Fertility Centre, New Zealand
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to see whether injecting local anaesthetic into the vaginal tissues,just prior to transvaginal egg collection,will decrease the amount of pain experienced by women having their eggs collected on an IVF cycle. All women will also receive intravenous sedation as required as well as a sleeping tablet thirty minutes prior to the procedure which is our routine procedure for egg collection.
Detailed Description
Transvaginal oocyte retrieval is the most common method of oocyte collection in IVF cycles. A variety of different methods are used to provide analgesia/anesthesia for oocyte collection. Our unit has always used an oral pre-medication followed by intravenous fentanyl during the procedure but this doesn't seem to provide adequate analgesia for some women. The aim of this study was to compare the addition of intravaginal local anaesthetic injection versus saline placebo to our usual analgesia regime to see whether less intravenous fentanyl was required and whether the women experienced less pain during oocyte collection.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility
Keywords
oocyte retrieval, pain relief, Local anaesthetic
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
75 (Actual)
8. Arms, Groups, and Interventions
Arm Title
LA
Arm Type
Active Comparator
Arm Description
Intravaginal and pre-peritoneal injection of 1% lignocaine into each side of the upper vagina under ultrasound guidance immediately prior to ultrasound guided transvaginal oocyte retrieval
Arm Title
P
Arm Type
Placebo Comparator
Arm Description
Intravaginal saline placebo injection into each side of upper vagina under ultrasound guidance immediately prior to transvaginal oocyte retrieval
Intervention Type
Drug
Intervention Name(s)
lignocaine
Intervention Description
20 mls of 1% lignocaine solution for injection, 10mls into each side of upper vagina, under ultrasound guidance immediately prior to transvaginal oocyte retrieval under ultrasound guidance from each ovary
Intervention Type
Drug
Intervention Name(s)
normal saline
Intervention Description
20mls of normal saline solution, 10mls injected each side into upper vagina under ultrasound guidance, immediately prior to ultrasound guided transvaginal oocyte retrieval from each ovary
Primary Outcome Measure Information:
Title
Total dose of iv fentanyl used during oocyte collection
Time Frame
Length of oocyte collection (minutes)
Secondary Outcome Measure Information:
Title
Pain score (cm on a Visual Analogue Scale) at 6 different points during oocyte collection
Time Frame
Actual point in time
Title
Length of oocyte collection procedure
Time Frame
Time taken (minutes)
Title
Occurence of nausea or vomiting
Time Frame
During oocyte collection procedure
Title
Administration of atropine or anti -emetic
Time Frame
During oocyte collection procedure
Title
Time spent in recovery room
Time Frame
Time from end of oocyte collection until discharge home
Title
No of oocytes collected
Time Frame
During oocyte collection procedure
Title
Number of oocytes fertilised
Time Frame
Assessed 18 hours after oocyte collection
Title
Pregnancy outcome
Time Frame
7 weeks gestation
Title
Number of embryos frozen
Time Frame
Within 6 days of oocyte collection
Title
Pulse rate at beginning and end of egg collection
Time Frame
Point in time
Title
Maximum pulse rate during oocyte collection
Time Frame
Point in time during oocyte collection procedure
10. Eligibility
Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
About to undergo transvaginal oocyte retrieval
Exclusion Criteria:
Already undergone oocyte retrieval and participated in study (i.e. 2nd or more oocyte collection procedure during study period)
Allergy to lignocaine
Oocytes only to be collected from one ovary
Procedure expected to be exceptionally painful
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sarah A Wakeman, FRANZCOG
Organizational Affiliation
The Fertility Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Fertility Centre
City
Christchurch
State/Province
Canterbury
ZIP/Postal Code
8014
Country
New Zealand
12. IPD Sharing Statement
Learn more about this trial
Local Anaesthetic for Transvaginal Egg Collection in IVF
We'll reach out to this number within 24 hrs